Form 8-K - Current report:
SEC Accession No. 0001274737-25-000018
Filing Date
2025-03-11
Accepted
2025-03-11 08:00:19
Documents
15
Period of Report
2025-03-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K exdx-20250311.htm   iXBRL 8-K 28006
2 EX-99.1 q42024exagenearningspressr.htm EX-99.1 116922
6 GRAPHIC exagen_fullxcmykxprintxnota.jpg GRAPHIC 56458
  Complete submission text file 0001274737-25-000018.txt   357092

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT exdx-20250311.xsd EX-101.SCH 1779
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT exdx-20250311_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT exdx-20250311_pre.xml EX-101.PRE 12506
17 EXTRACTED XBRL INSTANCE DOCUMENT exdx-20250311_htm.xml XML 2794
Mailing Address 1261 LIBERTY WAY VISTA CA 92081
Business Address 1261 LIBERTY WAY VISTA CA 92081 (760) 560-1501
EXAGEN INC. (Filer) CIK: 0001274737 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39049 | Film No.: 25725888
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)